CareerPlanSign in
This role has closed. Browse similar live roles below, or see all open jobs →

Alliance Manager, CPSS China

Shanghai Jing'An Office, CN💼 Full-time🗓 2026-07-27 → 2026-09-28

Core

Leads AstraZeneca's Alliance Management for CPSS outsourcing in China, managing CRO partnerships for toxicology, bioanalytical, and emerging modality work.

Role type

Senior Alliance Manager (Pharma R&D Outsourcing)

Builds

Locally enabled, globally aligned CRO partnership model for Safety Sciences and Bioanalysis in China

Domain

Pharmaceutical R&D, Toxicology, Bioanalysis, China Market

Required skills

CRO partnership management, vendor performance management, risk management, stakeholder management, project coordination, business acumen, scientific judgement, cross-cultural communication, process building

Preferred skills

Radioconjugate study experience, China regulatory landscape knowledge, academic collaboration experience, GLP regulations familiarity, digital tools in vendor management

Technologies

None explicitly stated

Responsibilities

Establish and maintain high-performing partnerships with China-based CROs, lead vendor performance management including scorecards and KPIs, conduct business reviews with vendor leadership, drive capability development plans for non-GLP to GLP-ready operations, support contracting strategy with Procurement and Legal, oversee specialized partnerships for radioconjugate and complex modalities, coordinate with global technical teams, provide hands-on operational support for outsourced studies, identify and resolve risks, establish governance frameworks, lead risk management activities, maintain audit readiness, represent China perspective in global strategy, support innovation with academic institutions and start-ups, contribute to long-term vendor strategy, influence complex stakeholder landscape, communicate complex information across languages and organizational levels

Seniority

Senior, hands-on IC

Sourced via workday · Listed on CareerPlan, which tracks 854,000+ jobs from 20+ sources.